This program is subject to modification.
Gérard CREUZET, Chairman of CAETS 202, NATF’s Delegate for Foreign Affairs
Denis RANQUE, NATF’s President and President of the CAETS Board of Directors (2022)
Sylvie RETAILLEAU, French Ministry for Higher Education and Research
Elias ZERHOUNI, Emeritus Professor, Radiology and Biomedical Engineering, Johns-Hopkins University – Fellow of the National Academy of Technologies of France and of the National Academy of Medicine
Christiane WOOPEN, Director of the Center for Life Ethics, University of Bonn; former Chair of the European Group on Ethics in Science and New Technologies, former member of IBC International Bioethics Committee UNESCO
(Coordinator: Patrick COUVREUR)
Major advances in technology are transforming the way scientists conduct research on diseases prevention and treatment. Drug discovery and delivery, as well as vaccines are currently entering a period of significant changes, due to a better exposition to emerging and innovative technologies. This is illustrated by the clever mRNA modification and nano formulation, as a unique and disruptive platform for vaccination. Artificial intelligence and high-throughput screening for drug discovery, as well as the use of nanotechnologies for drug targeting are other examples improving the treatment or diagnosis of severe diseases.
11:00 – 11:25 Speaker 1.1: Advanced nanomedicines and drug delivery
Patrick COUVREUR, Fellow of the French Académie des Sciences, of the National Academy of Technologies of France, of the National Academy of Medicine and the French Academy of Pharmacy
11:25 – 11:50 Speaker 1.2: The medicine of tomorrow
Thomas CLOZEL, Chief Executive Officer of Owkin
11:50 – 12:15 Speaker 1.3: mRNA as Medicine
Melissa J. MOORE, Chief Scientific Officer, Platform Research, Moderna
12:15 – 13:00 Q & A Panel
Patrick COUVREUR (moderator), Thomas CLOZEL, Melissa J. MOORE
(Coordinator: Erol GELENBE)
Digital technologies are pervasive in all aspects of human health, and areas emerge where fundamental aspects join hands with urgent needs. This session focuses on key areas where the encounter between ICT and health can enable major improvements in health, including « Digital twins » that learn from reality to reproduce the behaviour of the « real twin », the ICT assisted enhancement of human capabilities in extreme environments such as underwater or outer space, the need to ensure the privacy and information security of the whole chain of health provisioning through ICT, and one of the greatest technological challenges being addressed to understand and emulate the cognitive capabilities of human and animal brains, by representing in-silico the emergence of thought and intelligence. Our four renowned speakers will take us into the revolution in computing and communications that supports and enhances health and well-being, ending with a panel discussion that will include questions from the audience.
14:30 – 14:55 Speaker 2.1: Virtual twins for Healthcare
Patrick JOHNSON, Fellow of the National Academy of Technologies of France, Senior Vice-President Corporate Research & Science Strategy of Dassault Systemes
14:55 – 15:20 Speaker 2.2: Intelligent Analysis of Biomedical Images
Sushmita MITRA, Full professor at the Machine Intelligence Unit (MIU), Indian Statistical Institute, Kolkata, Fellow of Indian National Academy of Engineering
15:20 – 15:45 – Speaker 2.3: Private AI for human health and genomic data
Kristin LAUTER, Director of West Coast AI Research, Meta
(Coordinator: Erol GELENBE)
16:15 – 16:40 Speaker 2.4: Multiscale brain modelling for health and technology
Egidio D’ANGELO, Full Professor of Department of brain and behavioural sciences, University of Pavia
16:40 – 17:25 Q & A Panel
Erol GELENBE (moderator), Patrick JOHNSON, Kristin LAUTER, Sushmita MITRA, Egidio D’ANGELO
(Coordinators: Denis LE BIHAN & André SYROTA)
The past decade has seen several major “disruptive technologies” that refer to innovations that operate in a superior way to other products on the market, which leads to significant, usually positive change. This is mainly due to the evolution of new interdisciplinary research areas at the interface of biology, physics, mathematics and chemistry. Bioinformatics (with the development of Artificial Intelligence, Cognitive Computing, Machine Learning, Robotic Process Automation…), genomics, imaging, synthetic biology, systems biology, tissue engineering are examples. These new research areas have brought a revolution in medicine. Following an overview of R&D breakthroughs, two examples dealing with imagery are developed in more detail.
08:30 – 08:55 Speaker 3.1: Science without instruments is the ruin of the soul: the MRI example
Denis LE BIHAN, Fellow of the French Académie des Sciences, of the National Academy of Technologies of France, of the National Academy of Medicine, Director of Neurospin CEA, Saclay
08:55 – 09:20 Speaker 3.2: Ultrafast ultrasonic imaging : the future of ultrasound
Mathias FINK, Fellow of the French Académie des Sciences and of the National Academy of Technologies of France ESCPI Paris
09:20 – 09:45 Speaker 3.3: Micromachinery for Mechano-diagnostics
Gondi Kondaiah ANANTHASURESH, Professor of Mechanical Engineering and the Dean of Mechanical Sciences at the Indian Institute of Science, Bengaluru
09:45 – 10:05 Speaker 3.4 : Turning health tech into better health outcomes: how ready are we to adopt disruptive healthcare technologies?
Carmel HILLYARD, AM FTSE, Director, Australian Academy of Technology and Engineering (ATSE)
10:05 – 10:30 Q & A Panel
Denis LE BIHAN and André SYROTA (moderators), Mathias FINK, Gondi Kondaiah ANNATHASURESH, Carmel HILLYARD
(Coordinator: André SYROTA)
Digital twin models of human brains provide computational platforms for neuroscience research and increasingly find clinical translation in diagnostic and therapeutic applications. Virtual brains are data driven brain models derived from a patient’s own brain imaging data. With further refinement through methods from machine learning and artificial intelligence, they provide personalized brain network models for clinical decision making, tailored to the individual patient’s anatomy and pathology. Illustrative examples of virtual brain applications are found in epilepsy, neurosurgery and neurodegenerative diseases.
11:00 – 11:25 Speaker 4.1: Personalized virtual brain technology for drug-resistant epilepsy and neurosurgery
Viktor JIRSA, Director of the Inserm Systems Neuroscience Institute, Chief Science Officer EBRAINS
11:25 – 11:50 Speaker 4.2: A noninvasive EEG marker of the epileptic brain : how dynamic brain netword properties reveal epileptogenicity during rest
Sridevi SARMA, Associate director of the Johns Hopkins Institute for Computational Medicine, and an associate professor in the Johns Hopkins Department of Biomedical Engineering
11:50 – 12:15 Speaker 4.3: Using The Virtual Brain to trace trajectories of brain health in ageing
Randy McINTOSH, Director of the Institute for Neuroscience & Neurotechnology, Dept of Biomedical Physiology and Kinesiology, Simon Fraser University
12:15 – 13:00 Q & A Panel
André SYROTA (moderator), Viktor JIRSA, Sridevi SARMA, Randy MCINTOSH
(Coordinator : Bruno JARRY)
Technologies for repairing the human body, at the organ, cellular or whole limb levels are making their way in medicine. It includes methods to regrow, repair or replace damaged or diseased cells, tissues, organs, and even neurological pathways.
14:30 – 14:55 Speaker 5.1: Stem cells based technologies
Zhongchao HAN, Full Professor at the Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences, Fellow of the National Academy of Technologies of France, of the National Academy of Medicine
14:55 – 15:20 Speaker 5.2: Neuroprosthetic medicine: innovation, interdisciplinarity and translation
Stéphanie LACOUR, Full Professor, Foundation Bertarelli Chair in Neuroprosthetic Technology (EPFL)
15:20 – 15:45 Speaker 5.3: Restoring vision in blind patients: from prosthesis to optogenetic and sonogenetic therapy
Serge PICAUD, Director of the Paris Vision Institute
15:45 – 16:30 Q & A Panel
Bruno JARRY (moderator), Zhongchao HAN, Stéphanie LACOUR, Serge PICAUD
(Coordinators: Claudie HAIGNERE, Medical doctor, politician and former astronaut, Fellow of the National Academy of Technologies of France and Christiane WOOPEN, Director of the Center for Life Ethics, University of Bonn; former Chair of the European Group on Ethics in Science and New Technologies, former member of IBC International Bioethics Committee UNESCO)
Panelists:
Patrick COUVREUR, Fellow of the French Académie des Sciences, of the National Academy of Technologies of France, of the National Academy of Medicine and the French Academy of Pharmacy
Virginia DIGNUM, Professor at the Department of Computing Science at Umeå University, Sweden
Thierry MAGNIN, Fellow of the National Academy of Technologies of France, author of numerous works, especially on science and theology
Alison NOBLE, Technikos Professor of Biomedical Engineering at the University of Oxford, Fellow of the Royal Society and Fellow of the Royal Academy of Engineering
Jeroen VAN DEN HOVEN, University professor and full professor of Ethics and Technology at Delft University of Technology
Science in the Age of Experience 2022
To register, please use this link.
*to be confirmed